share_log

Teladoc Health | 10-Q: Q2 2024 Earnings Report

Teladoc Health | 10-Q: Q2 2024 Earnings Report

Teladoc Health | 10-Q：2024財年二季報
美股SEC公告 ·  2024/08/01 22:26

Moomoo AI 已提取核心訊息

Teladoc Health reported Q2 2024 revenue of $642.4 million, down 2% year-over-year, with a net loss of $837.7 million primarily due to a $790 million non-cash goodwill impairment charge related to its BetterHelp segment. The Integrated Care segment revenue grew 5% to $377.4 million, while BetterHelp revenue declined 9% to $265.0 million with a 14% decrease in average monthly paying users.Adjusted EBITDA increased 24% to $89.5 million, with Integrated Care segment Adjusted EBITDA growing 69% to $64.0 million on higher gross profit and lower operating expenses. BetterHelp segment Adjusted EBITDA decreased 26% to $25.5 million. The company maintained a strong liquidity position with $1.16 billion in cash and cash equivalents as of June 30, 2024.The company's U.S. Integrated Care membership grew 8% year-over-year to 92.4 million members, while chronic care program enrollment increased 9% to 1.17 million. Management continues to focus on operational efficiency, with cost reductions across multiple expense categories including technology, marketing, and general administrative expenses.
Teladoc Health reported Q2 2024 revenue of $642.4 million, down 2% year-over-year, with a net loss of $837.7 million primarily due to a $790 million non-cash goodwill impairment charge related to its BetterHelp segment. The Integrated Care segment revenue grew 5% to $377.4 million, while BetterHelp revenue declined 9% to $265.0 million with a 14% decrease in average monthly paying users.Adjusted EBITDA increased 24% to $89.5 million, with Integrated Care segment Adjusted EBITDA growing 69% to $64.0 million on higher gross profit and lower operating expenses. BetterHelp segment Adjusted EBITDA decreased 26% to $25.5 million. The company maintained a strong liquidity position with $1.16 billion in cash and cash equivalents as of June 30, 2024.The company's U.S. Integrated Care membership grew 8% year-over-year to 92.4 million members, while chronic care program enrollment increased 9% to 1.17 million. Management continues to focus on operational efficiency, with cost reductions across multiple expense categories including technology, marketing, and general administrative expenses.
Teladoc Health報告了2024年第二季度營業收入爲64240萬美元，同比下降2%，淨虧損爲83770萬美元，主要由於與BetterHelp業務相關的79000萬美元非現金商譽減值費用。綜合護理部門營業收入增長5%，達到37740萬美元，而BetterHelp的營業收入下降9%，爲26500萬美元，平均每月支付的用戶數減少了14%。調整後的息稅折舊攤銷前利潤（EBITDA）增長24%，達到8950萬美元，綜合護理部門調整後的EBITDA在毛利潤提高和營業費用降低的帶動下增長69%，達到6400萬美元。BetterHelp部門的調整後EBITDA下降26%，爲2550萬美元。到2024...展開全部
Teladoc Health報告了2024年第二季度營業收入爲64240萬美元，同比下降2%，淨虧損爲83770萬美元，主要由於與BetterHelp業務相關的79000萬美元非現金商譽減值費用。綜合護理部門營業收入增長5%，達到37740萬美元，而BetterHelp的營業收入下降9%，爲26500萬美元，平均每月支付的用戶數減少了14%。調整後的息稅折舊攤銷前利潤（EBITDA）增長24%，達到8950萬美元，綜合護理部門調整後的EBITDA在毛利潤提高和營業費用降低的帶動下增長69%，達到6400萬美元。BetterHelp部門的調整後EBITDA下降26%，爲2550萬美元。到2024年6月30日，公司保持強勁的流動性，現金及現金等價物爲11.6億。公司的美國綜合護理會員同比增長8%，達到92400000名會員，而慢性病護理項目的註冊人數增加9%，達到117000名。管理層繼續關注運營效率，在科技、市場營銷和一般行政費用等多個費用類別中進行成本削減。

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

獨立文件7  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    Forian
    FORA
    -- 3.590
    Ontrak
    OTRK
    -- 1.5900
    Mangoceuticals
    MGRX
    -- 4.840
    DarioHealth
    DRIO
    -- 0.700
    VSee Health
    VSEE
    -- 1.870
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    科技巨頭財報季如火如荼，英偉達壓軸會表現如何？
    週四， $亞馬遜 (AMZN.US)$ 該公司報告第四季度調整後每股收益爲1.86美元，高於1.50美元的預期，營業收入爲1877.9亿美元，高於1873.2亿美元的預期。公司預測下一季度營收將低於華爾街的預期，預計本季度最多爲1550亿美元，而分析師們希望達到1580亿美元。 展开
    亞馬遜收益預覽：通過猜測開盤價格獲得獎勵！